바이오기업의 코스닥 상장전략, “코넥스 통한 이전상장 효과적”

글 내용 전체보기

Update on review of valsartan medicines

글 내용 전체보기

With $140 Million State Incentives, Regeneron Expanding in New York and Adding 1,500 Jobs

글 내용 전체보기

Pfizer, Novartis to Close North Carolina Sites Ahead of Hurricane Florence

글 내용 전체보기

With a Bayer-Sanofi Executive Switch, Sanofi Creates 2 New Global Business Units

글 내용 전체보기

Takeda Could Sell Some Shire Assets to Pay Down Deal Debt

글 내용 전체보기

Report Sheds Light on Importance of Licensing Agreements in Biopharma Industry

글 내용 전체보기

Boehringer buys oncolytic virus startup ViraTherapeutics

글 내용 전체보기

Half of European studies fail to report results: BMJ report

글 내용 전체보기

Gilead taps gene editors at Precision BioSciences for hep B cure development

글 내용 전체보기

Vital Therapies falls 88%, ditches liver treatment after phase 3 fail

글 내용 전체보기

Coda Biotherapeutics launches with $19M to build ‘tunable’ gene therapy

글 내용 전체보기

Atreca bags $125M as solid tumor trial comes into view

글 내용 전체보기

Gilead, Galapagos’ filgotinib aces first phase 3, suggesting it can compete with AbbVie’s upadacitinib

글 내용 전체보기

Bristol-Myers Squibb begins phase 3 enrollment after psoriasis drug shows high skin clearance

글 내용 전체보기

Former Gilead CMO Cheng joins Akero as CEO, as company moves HQ

글 내용 전체보기

Xenon frees itself of some XEN1101 milestone obligations

글 내용 전체보기

OncoResponse raises $40M for cancer patient-sourced antibodies

글 내용 전체보기

Crescendo names ex-Roche leader Pisa as CMO

글 내용 전체보기

ImmusanT to develop Type 1 diabetes vaccine with JDRF backing

글 내용 전체보기

Sanofi prepped for production after EU Nanobody success

글 내용 전체보기